BMC Infectious Diseases (Jul 2019)
Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China
- Bing Ruan,
- Zhixin Yu,
- Shigui Yang,
- Kaijin Xu,
- Jingjing Ren,
- Jun Yao,
- Nanping Wu,
- Chengbo Yu,
- Min Deng,
- Tiansheng Xie,
- Ping Chen,
- Chencheng Wang,
- Yiping Li,
- Yanhong Zhao,
- Jifang Sheng,
- Yunde Hou,
- Zunyou Wu,
- Shuigao Jin,
- Yude Chen,
- Mengfeng Li,
- Fengcai Zhu,
- Hong Tang,
- Yuantao Hao,
- Xinghuo Pang,
- Lin Lu,
- Wen Yang,
- Zhengan Yuan,
- Aiqiang Xu,
- Zizhao Li,
- Mingjian Ni,
- Yongping Yan,
- Qiu Zhong,
- Lin Zhou,
- Guojian Li,
- Qun Meng,
- Jianping Hu,
- Hong Zhou,
- Guangyu Zhang,
- Dexin Li,
- Wei Jiang,
- Qing Li,
- Peixin Wu,
- Ruoqi Xing,
- Jinhui Gu,
- Di Gao,
- Lanjuan Li
Affiliations
- Bing Ruan
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Zhixin Yu
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Shigui Yang
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Kaijin Xu
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Jingjing Ren
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Jun Yao
- Zhejiang Provincial Center for Disease Control and Prevention
- Nanping Wu
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Chengbo Yu
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Min Deng
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Tiansheng Xie
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Ping Chen
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Chencheng Wang
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Yiping Li
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Yanhong Zhao
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Jifang Sheng
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- Yunde Hou
- Chinese Center for Disease Control and Prevention
- Zunyou Wu
- Chinese Center for Disease Control and Prevention
- Shuigao Jin
- Chinese Center for Disease Control and Prevention
- Yude Chen
- Peking University
- Mengfeng Li
- Sun Yat-sen University
- Fengcai Zhu
- Jiangsu Provincial Center for Disease Control and Prevention
- Hong Tang
- Sichuan University
- Yuantao Hao
- Peking University
- Xinghuo Pang
- Beijing Center for Disease Control and Prevention
- Lin Lu
- Yunnan Provincial Center for Disease Control and Prevention
- Wen Yang
- Sichuan Provincial Center for Disease Control and Prevention
- Zhengan Yuan
- Shanghai Center for Disease Control and Prevention
- Aiqiang Xu
- Shandong Provincial Center for Disease Control and Prevention
- Zizhao Li
- Henan Provincial Center for Disease Control and Prevention
- Mingjian Ni
- Xinjiang Provincial Center for Disease Control and Prevention
- Yongping Yan
- The Forth Military Medical University
- Qiu Zhong
- The Center of Tuberculosis control of Guangdong Province
- Lin Zhou
- The Center of Tuberculosis control of Guangdong Province
- Guojian Li
- Guangxi Provincial Center for Disease Control and Prevention
- Qun Meng
- National Statistical Information Center of China
- Jianping Hu
- National Statistical Information Center of China
- Hong Zhou
- National Statistical Information Center of China
- Guangyu Zhang
- The 309th Hospital of PLA
- Dexin Li
- Chinese Center for Disease Control and Prevention
- Wei Jiang
- The Digital Medical and Health Technology Research Institute of Zhejiang Province
- Qing Li
- National Health and Family Planning Commission of China
- Peixin Wu
- National Health and Family Planning Commission of China
- Ruoqi Xing
- National Health and Family Planning Commission of China
- Jinhui Gu
- National Health and Family Planning Commission of China
- Di Gao
- National Health and Family Planning Commission of China
- Lanjuan Li
- The State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Zhejiang University School of Medicine
- DOI
- https://doi.org/10.1186/s12879-019-4150-9
- Journal volume & issue
-
Vol. 19,
no. 1
pp. 1 – 10
Abstract
Abstract Background The major infectious diseases of hepatitis B has constituted an acute public health challenge in China. An effective and affordable HBV control model is urgently needed. A national project of Community-based Collaborative Innovation HBV (CCI-HBV) demonstration areas has optimized the existing community healthcare resources and obtained initial results in HBV control. Methods Based on the existing community healthcare network, CCI-HBV project combined the community health management and health contract signing service for long-staying residents in hepatitis B screening. Moreover, HBV field research strategy was popularized in CCI-HBV areas. After screening, patients with seropositive results were enrolled in corresponding cohorts and received treatment at an early stage. And the uninfected people received medical supports including health education through new media, behavior intervention and HBV vaccinations. In this process, a cloud-based National Information Platform (NIP) was established to collect and store residents’ epidemiological data. In addition, a special quality control team was set up for CCI project. Results After two rounds of screening, HBsAg positive rate dropped from 5.05% (with 5,173,003 people screened) to 4.57% (with 3,819,675 people screened), while the rate of new HBV infections was 0.28 per 100 person-years in the fixed cohorts of 2,584,322 people. The quality control team completed PPS sampling simultaneously and established the serum sample database with 2,800,000 serum samples for unified testing. Conclusions CCI-HBV project has established a large-scale field research to conduct whole-population screening and intervention. We analyzed the HBsAg prevalence and new infection rate of HBV in the fixed population for the epidemic trend and intervention effect. The purpose of CCI-HBV project is to establish and evaluate a practical model of grid management and field strategy, to realize the new goal to control hepatitis B in China. To provide policymakers with a feasible model, our results are directly applicable. Trial registration The project was funded by the Major Projects of Science Research for the 11th and 12th five-year plans of China, entitled “The prevention and control of AIDS, viral hepatitis and other major infectious diseases”, Grant Nos. 2009ZX10004901, 2011ZX10004901, 2013ZX10004904, 2014ZX10004007 and 2014ZX10004008.
Keywords